## Abstract ## Background Gene therapy has been identified as a promising treatment strategy for hormone refractory prostate cancer (HRPC). We report, for the first time, the use of the human osteocalcin (hOC) promoter to control inducible nitric oxide synthase (iNOS) transgene expression in HRPC.
✦ LIBER ✦
A specific radioimmunoassay for osteocalcin with advantageous species crossreactivity
✍ Scribed by Patricia Patterson-Allen; Cathy E. Brautigam; Richard E. Grindeland; C. Willet Asling; Paul X. Callahan
- Publisher
- Elsevier Science
- Year
- 1982
- Tongue
- English
- Weight
- 552 KB
- Volume
- 120
- Category
- Article
- ISSN
- 0003-2697
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Human osteocalcin: a strong promoter for
✍
Helen O. McCarthy; Jonathan A. Coulter; Jenny Worthington; Tracy Robson; David G
📂
Article
📅
2007
🏛
John Wiley and Sons
🌐
English
⚖ 818 KB
Development of a radioimmunoassay for pr
✍
Yu.S. Tatarinov; A. V. Sokolov
📂
Article
📅
1977
🏛
John Wiley and Sons
🌐
French
⚖ 493 KB
## Abstract Levels of human pregnancy‐specific or trophoblast‐specific beta~1~‐globulin (TBG) were measured by double‐antibody radioimmunoassay (RIA) in 103 patients with trophoblastic tumours and in 114 patients with a variety of non‐trophoblastic tumours. The sensitivity of RIA for TBG was about